David Tscharke

Prof. David Tscharke


Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2013 in Nature Immunology
Verified
Journal Article
Closed access
LMLaura K Mackay
Laura K Mackay
ARAzad Rahimpour
Azad Rahimpour
JMJoel Z Ma
Joel Z Ma
NCNicholas Collins
Nicholas Collins
ASAngus T Stock
Angus T Stock
TGThomas Gebhardt
Thomas Gebhardt

11 June 2006 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
MMMagdalini Moutaftsi
Magdalini Moutaftsi
BPBjoern Peters
Bjoern Peters
VPValerie Pasquetto
Valerie Pasquetto
DTDavid Tscharke
David Tscharke
JSJohn Sidney
John Sidney
ASAlessandro Sette
Alessandro Sette

8 January 2018 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
SPSimone L. Park
Simone L. Park
AZAli Zaid
Ali Zaid
JHJyh Liang Hor
Jyh Liang Hor
SCSusan N. Christo
Susan N. Christo
JPJulia E. Prier
Julia E. Prier
LMLaura K. Mackay
Laura K. Mackay

28 December 2004 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
DTDavid Tscharke
David Tscharke
GKGunasegaran Karupiah
Gunasegaran Karupiah
JZJie Zhou
Jie Zhou
TPTara Palmore
Tara Palmore
KIKari R. Irvine
Kari R. Irvine
JYJonathan W. Yewdell
Jonathan W. Yewdell
The large size of poxvirus genomes has stymied attempts to identify determinants recognized by CD8+ T cells and greatly impeded development of mouse smallpox vaccination models. Here, we use a vaccinia virus (VACV) expression library containing each of the predicted 258 open reading frames to identify five peptide determinants that account for approximately half of the VACV-specific CD8+ T cell response in C57BL/6 mice. We show that the primary immunodominance hierarchy is greatly affected by the route of VACV infection and the poxvirus strain used. Modified vaccinia virus ankara (MVA), a candidate replacement smallpox vaccine, failed to induce responses to two of the defined determinants. This could not be predicted by genomic comparison of viruses and is not due strictly to limited MVA replication in mice. Several determinants are immunogenic in cowpox and ectromelia (mousepox) virus infections, and immunization with the immunodominant determinant provided significant protection against lethal mousepox. These findings have important implications for understanding poxvirus immunity in animal models and bench-marking immune responses to poxvirus vaccines in humans.

28 May 2004 in Science
Verified
Journal Article
Closed access
PDF file
CNChristopher C. Norbury
Christopher C. Norbury
SBSameh Basta
Sameh Basta
KDKeri B. Donohue
Keri B. Donohue
DTDavid Tscharke
David Tscharke
MPMichael F. Princiotta
Michael F. Princiotta
JYJonathan W. Yewdell
Jonathan W. Yewdell
“Cross-priming” describes the activation of naïve CD8 + T cells by professional antigen-presenting cells that have acquired viral or tumor antigens from “donor” cells. Antigen transfer is believed to be mediated by donor cell–derived molecular chaperones bearing short peptide ligands generated by proteasome degradation of protein antigens. We show here that cross-priming is based on the transfer of proteasome substrates rather than peptides. These findings are potentially important for the rational design of vaccines that elicit CD8 + T cell responses.

1 May 1992 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ASA Simmons
A Simmons
DTDavid Tscharke
David Tscharke
The role of CD8+ T cells in resistance to herpes simplex virus (HSV) was examined. After cutaneous inoculation, HSV spreads to the peripheral nervous system (PNS) where it replicates in ganglionic neurons. In normal mice, replication of virus in the PNS was rapidly terminated and evidence of neuronal destruction, assessed by a quantitative histological assay, was sparse. Clearance of infectious virus was impaired, and a strikingly high proportion of ganglionic neurons was killed, in mice treated with an antibody that depleted them of CD8+ T cells. These results suggest that CD8+ T cells play an important role in maintaining the integrity of the sensory nervous system during primary infection with HSV. Therefore, viral epitopes recognized by CD8+ T cells and restricting class I major histocompatibility complex genes are, in principle, implicated as interacting genetic determinants of neurovirulence.